๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The discovery and validation of new drug targets in cancer

โœ Scribed by Sara A Courtneidge; Greg D Plowman


Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
672 KB
Volume
9
Category
Article
ISSN
0958-1669

No coin nor oath required. For personal study only.

โœฆ Synopsis


Advances in our understanding of the signal transduction pathways involved in cellular growth control have provided several new strategies for cancer therapy. Recent advances now make it possible to develop selective inhibitors targeting genomic instability, the growth, survival, and invasion of the tumor, and its nourishment through the growth of new blood vessels.


๐Ÿ“œ SIMILAR VOLUMES


Genomics and the discovery of new drug t
โœ David A Jones; Frank A Fitzpatrick ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 84 KB

Molecular medicine and genomics technologies are inseparable for defining new molecular targets. cDNA databases and elementary informatic tools provide instantaneous glimpses of gene families or tissue-restricted expression patterns as a means of new target identification. In addition, cDNA microarr

Role of mycobacteria effectors in phagos
โœ Wu Li; Jianping Xie ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 383 KB

Tuberculosis remains a serious global health threat with nearly 10 million new cases and 1.7 million deaths every year. The emergence of multi-drug resistant (MDR) and extensively drug resistant (XDR) strains of Mycobacterium tuberculosis (Mtb) further complicates this problem. It is pressing to fin